| Feature Type | Standardized | Nominal ANOVA | ||||
|---|---|---|---|---|---|---|
| mRNA | PX-12 | CTRPv2 | pan-cancer | AAC | 0.076 | 0.007 |
| mRNA | SB-525334 | CTRPv2 | pan-cancer | AAC | 0.097 | 0.007 |
| mRNA | SU11274 | CTRPv2 | pan-cancer | AAC | 0.092 | 0.007 |
| mRNA | Doxorubicin | gCSI | pan-cancer | AAC | -0.13 | 0.007 |
| mRNA | carboplatin:etoposide (40:17 mol/mol) | CTRPv2 | pan-cancer | AAC | 0.078 | 0.007 |
| mRNA | CD-437 | CTRPv2 | pan-cancer | AAC | 0.083 | 0.008 |
| mRNA | DBeQ | CTRPv2 | pan-cancer | AAC | 0.095 | 0.008 |
| mRNA | STF-31 | CTRPv2 | pan-cancer | AAC | 0.091 | 0.008 |
| mRNA | RAF265 | CTRPv2 | pan-cancer | AAC | 0.11 | 0.008 |
| mRNA | regorafenib | CTRPv2 | pan-cancer | AAC | 0.096 | 0.008 |